Jens Peter K.
- Country
- Germany
- Department
- Department of Othorinolaryngology, Head and Neck Surgery
Research Overview
- A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
- Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
- Phase 3 Study of NBTXR3 with Radiotherapy ± Cetuximab in Elderly Patients Ineligible for Platinum-Based Chemotherapy with Locally Advanced Head and Neck SCC
Data & Insights
Has run more than one trial at 25 of 112 partner sites.
Specializations
Head and Neck Oncology
This investigator specializes in treating head and neck squamous cell carcinoma (HNSCC), with particular focus on locally advanced stages. Their research encompasses both locoregionally advanced disease and innovative treatment approaches for resectable conditions.
- Stage III-IVA HNSCC management
- Neoadjuvant therapy strategies
- Radiotherapy optimization
Their expertise extends to treating elderly patients with locally advanced conditions who cannot receive platinum-based chemotherapy.
Nasopharyngeal Cancer
The investigator has developed specialized knowledge in treating EBV-positive nasopharyngeal carcinoma, particularly focusing on pediatric and young adult populations. Their work involves innovative combination therapy approaches.
- Pediatric and young adult treatment protocols
- Induction therapy optimization
- Radiotherapy dose adaptation
Their research includes developing protocols for children and young adults up to 25 years with locoregional disease.
Therapeutic Innovation
The investigator explores novel therapeutic combinations including immunotherapy applications and innovative radiation enhancement approaches in head and neck cancers.
- Combined modality treatments
- Radiation therapy enhancement
- Personalized treatment approaches
Their work includes evaluating intratumoral treatments activated by radiation therapy with or without targeted biological agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.